Is microRNA-33 an Appropriate Target in the Treatment of Atherosclerosis?

Nutrients. 2023 Feb 10;15(4):902. doi: 10.3390/nu15040902.

Abstract

The maintenance of cholesterol homeostasis is a complicated process involving regulation of cholesterol synthesis, dietary uptake and bile acid synthesis and excretion. Reverse cholesterol transport, described as the transfer of cholesterol from non-hepatic cells, including foam cells in atherosclerotic plaques, to the liver and then its excretion in the feces is important part of this regulation. High-density lipoproteins are the key mediators of reverse cholesterol transport. On the other hand, microRNA-33 was identified as a key regulator of cholesterol homeostasis. Recent studies indicate the impact of microRNA-33 not only on cellular cholesterol efflux and HDL production but also on bile metabolism in the liver. As proper coordination of cholesterol metabolism is essential to human health, discussion of recent findings in this field may open new perspectives in the microRNA-dependent treatment of a cholesterol imbalance.

Keywords: HDL; atherosclerosis; bile acids; cholesterol efflux; microRNA-33; reverse cholesterol transport.

Publication types

  • Review

MeSH terms

  • Atherosclerosis* / metabolism
  • Biological Transport
  • Cholesterol / metabolism
  • Humans
  • Lipoproteins, HDL / metabolism
  • Liver / metabolism
  • MicroRNAs* / metabolism
  • Plaque, Atherosclerotic* / metabolism

Substances

  • Cholesterol
  • Lipoproteins, HDL
  • MicroRNAs

Grants and funding

The APC was funded by the statutory funds of the Medical University of Lodz (503/6-086-01/503/-66-001).